Table 2 Maximal relaxation responses (%) and −logEC50 in isolated aorta arteries of 8 month-old variously treated spontaneously diabetic Goto-Kakizaki (GK) rats and age-matched non-diabetic Wistar rats.

From: The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes

 

W

GK

GKS

GKP

GKSP

ACh

  pEC50

7.59 ± 0.1

6.47 ± 0.18***

7.8 ± 0.24ϕϕϕ

7.64 ± 0.13ϕϕϕ

7.4 ± 0.18ϕϕ

  Maximal relaxation (%)

86.5 ± 3.8

50.7 ± 3.7***

63 ± 3.6***,ϕϕϕ

63.1 ± 2.7***,ϕϕϕ

74.3 ± 3.1 **,ϕϕϕ,§,#

SNP

  pEC50

7.7 ± 0.03

7.6 ± 0.03

7.96 ± 0.05 ***,ϕϕϕ

7.98 ± 0.04*,ϕϕϕ

7.9 ± 0.04*,ϕϕϕ

  Maximal relaxation (%)

97.1 ± 1.2

92.9 ± 1.4

98.1 ± 1.6

98.8 ± 1.4

97.5 ± 2.2

  1. Data are expressed as mean±SE (n = 12 animals in each group). pEC50 values are presented as the negative logarithm (−logEC50) of concentration of the agonist.
  2. *P < 0.05, **P < 0.01, ***P < 0.001 vs W rats.
  3. ϕϕP < 0.01, ϕϕϕP < 0.001 vs GK rats.
  4. §P < 0.05 vs GKS.
  5. #P < 0.05 vs GKP.